Cargando…
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells
Malignant melanoma is the most dangerous type of skin cancer. Although recent progress in treatment has been achieved, lack of response, drug resistance and relapse remain major problems. The tumor suppressor p53 is rarely mutated in melanoma, yet it is inactive in the majority of cases due to dysre...
Autores principales: | Sachweh, Marijke C.C., Stafford, William C., Drummond, Catherine J., McCarthy, Anna R., Higgins, Maureen, Campbell, Johanna, Brodin, Bertha, Arnér, Elias S.J., Laín, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599284/ https://www.ncbi.nlm.nih.gov/pubmed/26029997 |
Ejemplares similares
-
Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin
por: Saei, Amir Ata, et al.
Publicado: (2020) -
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression
por: Sachweh, M C C, et al.
Publicado: (2013) -
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
por: Sabatier, Pierre, et al.
Publicado: (2021) -
Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)
por: Chiappetta, Giovanni, et al.
Publicado: (2022) -
TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole
por: Oberstadt, Moritz, et al.
Publicado: (2018)